MAPK8IP2 is a potential prognostic biomarker and promote tumor progression in prostate cancer

MAPK8IP2 is a potential prognostic biomarker and promote tumor progression in prostate cancer

Abstract Background MAPK8IP2 is one of the JNK-interacting proteins (JIPs) family members, and is involved in the regulation of the JNK and P38 MAPK signaling pathways. MAPK8IP2 has been reported to be closely associated with several cancers. However, the biological function of MAPK8IP2 in prostate...

Full description

Bibliographic Details
Main Authors: Zhenhao Zeng, Wenrui He, Yi Jiang, Hao Jiang, Xiaofeng Cheng, Wen Deng, Xiaochen Zhou, Cheng Zhang, Gongxian Wang
Format: Article
Language:English
Published: BMC 2022-11-01
Series:BMC Cancer
Subjects:
MAPK8IP2
Prostate cancer
Methylation
Prognosis
Tumor progression
Online Access:https://doi.org/10.1186/s12885-022-10259-2

Similar Items

Similar Items